Which enzyme do oseltamivir, zanamivir, and peramivir inhibit to prevent new virus particles from leaving an infected cell?
Choose an answer, then check it.
Clinical Pharmacology · Antiviral Medications
Influenza Medications
On this page 6 sections
In 30 seconds
Influenza antivirals target the virus itself but do not cure the illness outright: neuraminidase inhibitors (oseltamivir, zanamivir, peramivir) block release of new virus particles from infected cells, while baloxavir marboxil blocks an earlier replication step. Benefit is greatest when treatment starts early, is modest in healthy adults, and matters far more for preventing complications in high-risk patients. None replace the flu vaccine, which remains the primary defense.
The college version
Neuraminidase Inhibitors
Oseltamivir, zanamivir, and peramivir inhibit neuraminidase, a surface enzyme influenza uses to release newly assembled virions from an infected cell's membrane. Without it, viral particles clump at the surface instead of spreading onward. Oseltamivir is an oral prodrug activated in the liver, the most common outpatient and post-exposure prophylaxis choice. Zanamivir is inhaled through a breath-activated device; because it can trigger bronchospasm, it carries a caution against use in asthma or chronic obstructive pulmonary disease. Peramivir is given intravenously, useful for hospitalized patients or those unable to take oral or inhaled medication.
Baloxavir Marboxil
Baloxavir marboxil is mechanistically distinct: it inhibits the polymerase acidic endonuclease, an enzyme influenza needs to "cap-snatch" host mRNA and begin transcribing its own genes, preventing new viral genetic material from forming at all rather than only trapping finished particles. Its main advantage is single-dose oral administration, improving adherence.
The Obsolete Adamantanes
Amantadine and rimantadine once treated influenza A by blocking the M2 ion channel needed for viral uncoating. Circulating strains have since developed near-universal resistance, so these drugs are no longer recommended, though they remain a useful lesson in how fast resistance can retire an antiviral class.
Timing and Who Truly Benefits
Benefit depends heavily on starting treatment early, before viral replication peaks. In otherwise healthy people, early treatment shortens symptoms only modestly. The stronger argument for treatment lies in high-risk populations, where the goal shifts from shortening illness to preventing complications such as pneumonia and hospitalization. High-risk groups include young children, older adults, pregnant patients and those in the early postpartum period, immunocompromised individuals, people with chronic cardiopulmonary or metabolic disease, and anyone already hospitalized with influenza. In outbreaks such as long-term care facilities, these agents also serve as post-exposure prophylaxis, protecting exposed but not-yet-infected residents.
Adverse Effects and Dose Adjustment
Oseltamivir's most common adverse effects are nausea and vomiting, often mitigated by taking it with food. Rare neuropsychiatric events, including abnormal behavior and self-injury, have been reported, particularly in adolescents, warranting monitoring after starting therapy. Because these agents are cleared renally, dose adjustment is required with reduced kidney function to avoid toxicity.
The Public Health Frame
Annual vaccination is the primary strategy for preventing influenza at a population level, reducing how many people become infected in the first place. Antivirals supplement vaccination by treating breakthrough infections and protecting the highest-risk patients, but never substitute for the vaccine itself.
Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of a flu virus as a tiny factory in your body making copies of itself and shipping them out to infect more cells. Most flu medicines jam the loading dock: copies get stuck and can't spread further. Baloxavir works earlier — it jams the assembly line, so the factory barely makes new copies at all. These medicines work best taken soon after getting sick, while the factory is just ramping up. For a healthy kid, they might only help you feel better a little sooner. But for someone whose body struggles to fight germs — a baby, a grandparent, someone already very sick — shutting the factory down early can mean the difference between a bad week and a hospital trip. Locking the doors before the factory opens beats jamming it once it's running, so a yearly flu shot is still the best plan; the medicines are just a backup.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A nurse cares for a healthy young adult with mild flu symptoms who wants an antiviral "to feel better fast." What should the nurse explain about the expected benefit here?
Show answer
Expect only a modest benefit
The nurse should explain that in a healthy young adult, an antiviral started early may shorten symptoms somewhat but only slightly — it won't make the flu vanish overnight. These drugs matter most for people at higher risk of complications, which this patient is not.
A long-term care facility has a confirmed influenza outbreak. How might an antiviral be used in residents who are exposed but not yet symptomatic, and why does this matter in that setting?
Show answer
Used as post-exposure prophylaxis for exposed residents
The antiviral can be given to residents who were exposed but aren't sick yet, aiming to prevent infection from taking hold at all. This matters because such residents are often older or frail, making serious complications far more likely if the virus spreads unchecked.
Quick check
3 questions here. Answers stay hidden until you check.
A patient with poorly controlled asthma needs an influenza antiviral. Which agent should generally be avoided due to bronchospasm risk?
Choose an answer, then check it.
Why are amantadine and rimantadine no longer recommended for influenza A?
Choose an answer, then check it.
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.